Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengzhen Shen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacological Research|May 10, 2025
Corrigendum to "Curcumin modulates β-catenin stabilization via targeting proteasomal deubiquitinating enzyme USP14" [Pharmacol. Res. 216 (2025) 107745]Mengzhen Shen, Lizhe Chen, Jie Jiang, et al.
Pharmacological Research|November 6, 2021
Small molecule targeting topoisomerase 3β for cancer therapyXue Zhang, Lei Wang, Qi Zhang, et al.
Pharmacological Research|April 28, 2025
Curcumin modulates β-catenin stabilization via targeting proteasomal deubiquitinating enzyme USP14<sup>☆</sup>Mengzhen Shen, Lizhe Chen, Jie Jiang, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 1, 2023
Small molecule activates citrullination through targeting PAD2Xue Zhang, Mengzhen Shen, Huimin Zhu, et al.
Pharmacological Research|May 1, 2026
Orlistat targets NEDD8 conjugating enzyme UBC12 for cancer therapyMengzhen Shen, Huihui Li, Ying Xuan, et al.
The FEBS Journal|July 9, 2024
TRAF2 associates with cullin neddylation complex assemblyTiantian Wang, Qi Zhang, Yu Xu, et al.
Cell Reports|February 2, 2022
Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2Rong Yan, Hongyan Zhu, Piao Huang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacological Research|May 10, 2025
Corrigendum to "Curcumin modulates β-catenin stabilization via targeting proteasomal deubiquitinating enzyme USP14" [Pharmacol. Res. 216 (2025) 107745]Mengzhen Shen, Lizhe Chen, Jie Jiang, et al.
Pharmacological Research|November 6, 2021
Small molecule targeting topoisomerase 3β for cancer therapyXue Zhang, Lei Wang, Qi Zhang, et al.
Pharmacological Research|April 28, 2025
Curcumin modulates β-catenin stabilization via targeting proteasomal deubiquitinating enzyme USP14<sup>☆</sup>Mengzhen Shen, Lizhe Chen, Jie Jiang, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 1, 2023
Small molecule activates citrullination through targeting PAD2Xue Zhang, Mengzhen Shen, Huimin Zhu, et al.
Pharmacological Research|May 1, 2026
Orlistat targets NEDD8 conjugating enzyme UBC12 for cancer therapyMengzhen Shen, Huihui Li, Ying Xuan, et al.
The FEBS Journal|July 9, 2024
TRAF2 associates with cullin neddylation complex assemblyTiantian Wang, Qi Zhang, Yu Xu, et al.
Cell Reports|February 2, 2022
Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2Rong Yan, Hongyan Zhu, Piao Huang, et al.
Pageof 1